Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Aug. 5, 2013

View Archived Issues

Chinese regulations could prove to be a boon to exporters

New regulations introduced in July in China, could raise costs for domestic device manufacturers but may prove to be a boon for importers. Read More

Mitek Sports launches new Healix Knotless Anchor

NewCo on the Go: Optimum TAV achieves pre-clinical milestone

Washington roundup: GAO decries self-referral for IMRT; docs say 'misleading'

New Ventures: Harvard Bioscience to separate from its HART subsidiary

Product News:

Washington roundup II: Cardiologists surprised CMS ready to dump INTERMACS

People in the News:

Financings roundup: Truven Health closeson $372M senior note exchange offer

Deals roundup: ICU Medical rumored to be in talks to sell itself to GTCR

Keeping you up to date on recent developments in neurology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.